Succinic acid monomethyl ester protects rat pancreatic islet secretory potential against interleukin-1 beta (IL-1 beta) without affecting glutamate decarboxylase expression or nitric oxide production

FEBS Lett. 1994 Jan 17;337(3):298-302. doi: 10.1016/0014-5793(94)80213-0.

Abstract

Rat pancreatic islets exposed to interleukin-1 beta (IL-1 beta) in the presence of succinic acid monomethyl ester (SAM) have a higher insulin release in response to glucose and higher glucose oxidation rates, as compared to islets exposed to IL-1 beta alone. These beneficial effects of SAM were not accompanied by any decrease in IL-1 beta-induced nitric oxide (NO) production nor inhibition of aconitase activity. Moreover, SAM did not increase biosynthesis of glutamate decarboxylase. SAM apparently improves beta-cell function mostly by increasing the capacity of these cells to endure NO exposure and partial blockage of the Krebs cycle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aconitate Hydratase / metabolism
  • Animals
  • Glucose / pharmacology
  • Glutamate Decarboxylase / metabolism*
  • Insulin / metabolism*
  • Insulin Secretion
  • Interleukin-1 / pharmacology*
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism*
  • Male
  • Nitric Oxide / biosynthesis*
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins / pharmacology
  • Succinates / pharmacology*

Substances

  • Insulin
  • Interleukin-1
  • Recombinant Proteins
  • Succinates
  • Nitric Oxide
  • Glutamate Decarboxylase
  • Aconitate Hydratase
  • Glucose
  • monomethyl succinate